FDA
approval
· 2023-12-15
FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Aurolife Pharma, LLC)
Summary
FDA approved a supplemental application for HYDROCODONE BITARTRATE AND IBUPROFEN from Aurolife Pharma, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE AND IBUPROFEN)